Business profile & competitive position
Church & Dwight Co., Inc. (CHD) operates in the Consumer Defensive sector under the Household & Personal Products industry classification. The company is a large-cap household name with a current market capitalization of $24.4 billion, built around a portfolio of everyday consumer staples. A net margin of 12.0% and return on equity (ROE) of 17.8% suggest a business that earns consistently above its cost of equity and converts sales into shareholder returns efficiently. Those figures are consistent with the economics of branded consumer products, where pricing power, repeat purchases, and shelf-space relationships can protect profitability. A beta of 0.47 underscores the defensive profile: the stock historically moves less than half as much as the overall equity market during broad swings. In plain terms, the numbers portray a slow-and-steady operator rather than a high-growth disruptor.
Financial posture
CHD currently trades at a price-to-earnings ratio of 33.0, a multiple that sits at the premium end of the consumer-staples spectrum. That valuation implies the market is pricing in durable demand and reliable cash flows, but it also leaves limited room for disappointment. The combination of a 12.0% net margin and 17.8% ROE supports the premium to some extent, since both metrics point to disciplined capital allocation and solid operating leverage. At the same time, P/E 33.0 handcuffs the stock to the perception of stability; any squeeze in margins, volume deceleration, or rise in interest rates that makes future cash flows less valuable can weigh on the multiple. The 0.47 beta reinforces this setup: investors often look at CHD as a bond-like equity proxy, which can make it sensitive to shifts in real yields and risk appetite even when the underlying business is stable.
Macro & geopolitical exposure
As a Household & Personal Products company, CHD is exposed to the standard macro cross-currents of the consumer-staples space. Input costs—resins, paper pulp, chemicals, fragrances, and other raw materials—directly affect gross margins, so commodity inflation or supply-chain bottlenecks can pressure profitability. Freight and logistics costs matter too, especially when fuel prices move sharply. Trade policy is another relevant channel: tariffs on imported packaging materials, components, or finished goods can raise costs, while currency translation affects the value of overseas revenue reported in U.S. dollars. On the regulatory side, the industry faces oversight from agencies like the FDA and FTC around product claims, labeling, and safety, any tightening of which can drive compliance expense. Private-label competition and retailer consolidation also shape pricing power. Importantly, demand for most of CHD's categories is non-discretionary, so volume shocks are usually milder than for cyclical sectors, but margin shocks from cost or policy changes can still move the stock.
Recent developments
Recent news has centered on the company's second-quarter 2026 update and a broader competitive comparison. On July 31, 2026, Seeking Alpha published the Q2 2026 earnings call transcript, while GuruFocus reported on the same event, highlighting a 5.8% organic sales surge and a raised full-year outlook. MarketBeat also published Q2 earnings call highlights the same day. The message across those reports is that management saw enough momentum to lift guidance, which is the kind of catalyst investors in defensive names watch closely. More recently, on August 7, 2026, Defense World ran a head-to-head review pitting Church & Dwight against Reynolds Consumer Products (REYN), a useful reminder that CHD is being evaluated not just in isolation but against other large-cap defensive peers at a time when staples multiples remain elevated.
Earnings behavior & post-earnings drift
Over the last eight reported quarters, CHD has beaten consensus earnings expectations six times, for an 86% beat rate, with an average surprise of 5.2%. The average five-day price move following earnings across those quarters is +1.32%, classified as an upward drift. On the surface, that looks like the classic post-earnings drift pattern: a company with a history of beats tends to drift higher after the report. But the underlying quarter-by-quarter data tell a more complicated story.
On May 1, 2026, CHD delivered a 2.0% earnings beat on an actual EPS of $0.95 versus an estimate of $0.931, yet the stock fell 3.26% the next day and 2.69% over the following five days. On October 31, 2025, the company beat by a much wider 10.1% margin—actual EPS $0.81 versus estimate $0.736—but the stock still dropped 1.61% the next session and 0.95% over five days. Those two quarters show that even on beats, the post-earnings drift did not reliably continue in the direction of the surprise. Meanwhile, on July 31, 2026, CHD missed by a slim 0.7% with actual EPS of $0.89 versus estimate $0.896, and the stock actually rose 1.21% the next day and 4.48% over the following five days. That counterintuitive reaction suggests the market's real expectation, the unofficial consensus, or management's guidance commentary can matter more than the headline beat-or-miss print against the published number. For the upcoming October 30, 2026 report, the consensus EPS estimate is $0.90. Traders should keep in mind that with CHD's 86% beat history and 33.0 P/E, guidance tone and margin commentary may drive the post-report price action more than the reported EPS alone.
Frequently Asked Questions
What does CHD's 86% beat rate but mixed post-earnings price action mean for traders?
The historical beat rate of 6 out of 8 quarters, with an average 5.2% earnings surprise, would normally suggest post-report upside. But CHD's actual next-day and five-day reactions have been inconsistent: for example, the May 2026 and October 2025 beats were followed by declines, while the July 2026 miss was followed by gains. This means traders should not assume a beat automatically equals a pop, and should pay attention to guidance and the market's real expectation rather than the consensus number alone.
Why does CHD trade at a P/E of 33.0?
The premium P/E reflects CHD's defensive Consumer Defensive profile, its 12.0% net margin, and its 17.8% ROE. The stock also carries a low 0.47 beta, which can make it attractive to investors seeking stability. However, a 33.0 multiple means the stock is priced for consistency, so any disappointment on margins, volume, or guidance can pressure the multiple.
What should investors watch in the October 30, 2026 earnings report?
Besides the consensus EPS estimate of $0.90, focus on organic sales momentum, gross margin direction, and any update to full-year guidance following the Q2 guidance raise. Because CHD's valuation already embeds high expectations, the stock's reaction may hinge more on forward-looking commentary than the single-quarter EPS print.
If you're looking for a deeper read on whether institutional analysts are growing more bullish or cautious after the latest quarter, you can review the full institutional verdict and recent rating changes for CHD below.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-31 | $0.89 | $0.896 | -0.7% | +1.21% | +4.48% |
| 2026-05-01 | $0.95 | $0.931 | +2% | -3.26% | -2.69% |
| 2026-01-30 | $0.86 | $0.836 | +2.9% | +1.13% | +4.45% |
| 2025-10-31 | $0.81 | $0.736 | +10.1% | -1.61% | -0.95% |
| 2025-08-01 | $0.94 | $0.857 | +9.7% | - | - |
| 2025-05-01 | $0.91 | $0.896 | +1.6% | - | - |
Previous CHD editions
Get the institutional verdict on CHD
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the CHD verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.